HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

This Week on NeurologyLive — August 16, 2021

Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

Today is the season 3 premiere for the MJH Life Sciences Medical World News streaming channel! Now is your chance to see new episodes of your favorite original shows. NeurologyLive is contributing to Deep Dive this week, which will feature a conversation with Alireza Atri, MD, PhD, the director of the Banner Sun Health Research Institute, about the recently developed appropriate use criteria for the newly approved Alzheimer disease drug, aducanumab (Aduhelm; Biogen/Eisai). Additionally, there are 2 seasons worth of episodes to watch for all of our original shows, so check out the on-demand library of available interviews, debates, and bits of advice.

To catch up and check out what's on the Medical World News channel now, or check out hundreds of episodes on-demand, click here.

NeurologyLive's August 2021 print issue is set to go live online this week. Every day, we'll be publishing a feature story from the issue, with our latest Letter from the Editor kicking things off today, August 16. Our guest editor in chief, Jurriaan Peters, MD, PhD, details the need to redefine outcomes in pediatric epilepsy surgery in a preview of the issue's cover story from Rohini Coorg, MD. Our features tackle the differentiation of tardive dyskinesia from other movement disorders, by Laxman Bahroo, DO, and Jonathan Isaacson, MD; and the clinical application of the latest updates to the secondary stroke prevention guidelines by Sana Somani, MD, and Prachi Mehndiratta, MBBS, FAHA.

To catch up on the issue or download a PDF, click here.

New episodes of our Insights series, "Case-Based Insights: Expert Perspectives on the Treatment of Adult-Onset SMA," will premiere this week, featuring expert neurologists Arun S. Varadhachary, MD, PhD, and James Wymer, MD, who discuss individual patient cases involving the treatment of adult-onset spinal muscular atrophy (SMA). Their conversations thus far have covered the presentation of the disease, treatment options for management, and the lingering unmet needs for this population, among other topics.

To catch up on the series, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, August 18. This week, James Galvin, MD, neurologist, professor of neurology, and director of the Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, discusses a multitude of projects he and his colleagues have conducted recently, including studies on associations of greenspaces and cognitive and brain volumes and use of the Moca-T telephone to increase dementia education. He also detailed a newly funded NIH grant and what we currently know about the associations between COVID-19 infection and increased risk of dementia.

To check out the prior NeuroVoices conversations, click here.

Our final episodes from the NeurologyLive Peer Exchange series featuring a number of multiple sclerosis (MS) experts, called "Optimal Management of Relapsing Multiple Sclerosis" are set to go live this week! The experts, including Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD, explore several topics pertaining to the diagnosis and treatment of relapsing MS in these new episodes, after wrapping up a discussion about the role of shared decision-making in the management of MS.

To catch up on the series, click here.

In Case You Missed It: The first of our new feature series, Gold Standard Centers, has been published! This story dives headfirst into the care being provided by the NYU Langone Health Comprehensive Epilepsy Center, featuring insight from its team of top talents, whose contributions to drug development and improvement of patient quality of life stand among the field's most important.

To check out the feature story, click here.


——————————————————

The 3rd Annual International Congress on the Future of Neurology® is coming up! The hybrid meeting, which will showcase the most recent advancements in neurologic disorders, is being held September 17-18, 2021, at the InterContinental New York Barclay. The target audience for this activity is physicians who treat patients with neurologic disorders. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the management of patients with neurologic disorders are also invited to participate.

The learning objectives of the program are:

  • Outline current and emerging diagnostic concepts for neurologic disorders
  • Explain clinical evidence for the management of neurologic disorders across multiple lines of care
  • Summarize the mechanism of action of therapeutic agents used to manage neurologic disorders
  • Prepare strategies for early recognition and management of treatment-related toxicities associated with neurologic therapies
  • Apply multidisciplinary care strategies for optimizing patient outcomes in the setting of neurologic disorders
  • Assess recent landmark data from clinical trials in the context of evolving treatment paradigms in neurology